Evidence map›Paper›PMID 39049596›Full record

ArticleHaematologica2025

Increased frequency of clonal hematopoiesis of indeterminate potential in Bloom syndrome probands and carriers.

Isabella Lin, Angela Wei, Tsumugi A Gebo, Paul C Boutros, Maeve Flanagan, Nicole Kucine, Christopher Cunniff, Valerie A Arboleda, Vivian Y Chang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Haematologica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Isabella LinDepartment of Human Genetics, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA; Department of Computational Medicine, David Geffen School of Medicine, UCLA, Los Angeles, CA.
Angela WeiDepartment of Human Genetics, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA; Department of Computational Medicine, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA; Interdepartmental BioInformatics Program, UCLA, Los Angeles, CA.
Tsumugi A GeboJonsson Comprehensive Cancer Center, UCLA, Los Angeles, CA, USA; Institute for Precision Health, University of California Los Angeles, Los Angeles, CA.
Paul C BoutrosDepartment of Human Genetics, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA; Interdepartmental BioInformatics Program, UCLA, Los Angeles, CA, USA; Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, CA, USA; Institute for Precision Health, University of California Los Angeles, Los Angeles, CA, USA; Department of Urology, University of California Los Angeles, Los Angeles, CA, USA; Molecular Biology Institute, University of California, Los Angeles, CA.
Maeve FlanaganDepartment of Pediatrics, Weill Cornell Medicine, New York, NY.
Nicole KucineDepartment of Pediatrics, Weill Cornell Medicine, New York, NY.
Christopher CunniffDepartment of Pediatrics, Weill Cornell Medicine, New York, NY.
Valerie A ArboledaDepartment of Human Genetics, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA; Department of Computational Medicine, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA; Interdepartmental BioInformatics Program, UCLA, Los Angeles, CA, USA; Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, CA, USA; Molecular Biology Institute, University of California, Los Angeles, CA.
Vivian Y ChangJonsson Comprehensive Cancer Center, UCLA, Los Angeles, CA, USA; Institute for Precision Health, University of California Los Angeles, Los Angeles, CA, USA; Division of Pediatric Hematology/ Oncology, UCLA, Los Angeles, CA, USA; Children's Discovery and Innovation Institute, UCLA, Los Angeles, CA. vchang@mednet.ucla.edu.

Funding

Women's CancersP30CA016042 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Samuel Wheeler French · 1985 to 2026
$134.5M
UCLA-Caltech Medical Scientist Training ProgramT32GM008042 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI AJIJOLA, OLUJIMI A, DAWSON, DAVID WAYNE · 1985 to 2023
$29.9M
Unraveling correlations between Mendelian and common disease using functional genomicsDP5OD024579 · OD · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ARBOLEDA, VALERIE A · 2017 to 2021
$1.9M
Regulation of Stem Cell Aging and Cancer by the Vascular NicheK08HL138305 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI CHANG, VIVIAN Y-J · 2017 to 2021
$891k
NCI NIH HHS P30 CA016042NHLBI NIH HHS K08 HL138305NIGMS NIH HHS T32 GM008042NIH HHS DP5 OD024579
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39049596
PMCPMC11694119

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.